chr2-105337597-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024093.3(C2orf49):c.10G>A(p.Asp4Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000207 in 1,613,194 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024093.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C2orf49 | NM_024093.3 | c.10G>A | p.Asp4Asn | missense_variant | 1/4 | ENST00000258457.7 | NP_076998.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C2orf49 | ENST00000258457.7 | c.10G>A | p.Asp4Asn | missense_variant | 1/4 | 1 | NM_024093.3 | ENSP00000258457 | P1 | |
C2orf49 | ENST00000410049.1 | c.10G>A | p.Asp4Asn | missense_variant | 1/5 | 1 | ENSP00000386361 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152046Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000410 AC: 101AN: 246150Hom.: 0 AF XY: 0.000432 AC XY: 58AN XY: 134132
GnomAD4 exome AF: 0.000199 AC: 291AN: 1461148Hom.: 1 Cov.: 44 AF XY: 0.000205 AC XY: 149AN XY: 726900
GnomAD4 genome AF: 0.000283 AC: 43AN: 152046Hom.: 0 Cov.: 30 AF XY: 0.000337 AC XY: 25AN XY: 74284
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The c.10G>A (p.D4N) alteration is located in exon 1 (coding exon 1) of the C2orf49 gene. This alteration results from a G to A substitution at nucleotide position 10, causing the aspartic acid (D) at amino acid position 4 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at